Citadel Advisors’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.41M | Buy |
204,217
+150,581
| +281% | +$4.73M | ﹤0.01% | 1707 |
|
|
2025
Q1 | $1.59M | Sell |
53,636
-22,034
| -29% | -$654K | ﹤0.01% | 2806 |
|
|
2024
Q4 | $2.23M | Buy |
75,670
+16,562
| +28% | +$489K | ﹤0.01% | 2492 |
|
|
2024
Q3 | $1.84M | Sell |
59,108
-169,844
| -74% | -$5.29M | ﹤0.01% | 2580 |
|
|
2024
Q2 | $7.76M | Buy |
228,952
+166,927
| +269% | +$5.66M | ﹤0.01% | 1380 |
|
|
2024
Q1 | $4.03M | Sell |
62,025
-178,331
| -74% | -$11.6M | ﹤0.01% | 1921 |
|
|
2023
Q4 | $16.4M | Buy |
240,356
+68,784
| +40% | +$4.7M | ﹤0.01% | 947 |
|
|
2023
Q3 | $8.9M | Buy |
171,572
+135,695
| +378% | +$7.04M | ﹤0.01% | 1231 |
|
|
2023
Q2 | $2.15M | Sell |
35,877
-24,445
| -41% | -$1.47M | ﹤0.01% | 2371 |
|
|
2023
Q1 | $2.98M | Sell |
60,322
-139,266
| -70% | -$6.89M | ﹤0.01% | 2188 |
|
|
2022
Q4 | $11.4M | Sell |
199,588
-94,814
| -32% | -$5.41M | ﹤0.01% | 1212 |
|
|
2022
Q3 | $13.8M | Buy |
294,402
+209,902
| +248% | +$9.85M | ﹤0.01% | 1055 |
|
|
2022
Q2 | $3.15M | Buy |
84,500
+24,774
| +41% | +$924K | ﹤0.01% | 2306 |
|
|
2022
Q1 | $1.79M | Buy |
59,726
+47,603
| +393% | +$1.42M | ﹤0.01% | 3128 |
|
|
2021
Q4 | $415K | Sell |
12,123
-10,405
| -46% | -$356K | ﹤0.01% | 4781 |
|
|
2021
Q3 | $835K | Sell |
22,528
-28,782
| -56% | -$1.07M | ﹤0.01% | 3970 |
|
|
2021
Q2 | $2M | Sell |
51,310
-126
| -0.2% | -$4.92K | ﹤0.01% | 3215 |
|
|
2021
Q1 | $2.19M | Buy |
+51,436
| New | +$2.19M | ﹤0.01% | 3058 |
|